Key Insights

Highlights

Success Rate

100% trial completion (above average)

Treatment Research

6 treatments under study, led by Shorter Or Longer Period Of Specific Dietary Restrictions

Research Leaders

17 sponsors active, led by Imperial College London

Related Conditions

Often studied with 6 related conditions

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 40/100

Termination Rate

0.0%

0 terminated out of 8 trials

Success Rate

100.0%

+13.4% vs benchmark

Late-Stage Pipeline

13%

1 trials in Phase 3/4

Results Transparency

20%

1 of 5 completed with results

Key Signals

1 with results100% success

Data Visualizations

Phase Distribution

5Total
Not Applicable (3)
Phase 1/2 (1)
Phase 4 (1)

Trial Status

Completed5
Not Yet Recruiting1
Active Not Recruiting1
Unknown1

Trial Success Rate

100.0%

Benchmark: 86.6%

Based on 5 completed trials

Clinical Trials (8)

Research Network

Common Treatments

  • Shorter Or Longer Period Of Specific Dietary Restrictions1
  • Assigned Period Of Specific Dietary Restrictions1
  • Administration Of Live Attenuated Influenza Vaccine1
  • Administration Of Live Attenuated Influenza Vaccine Laiv1
  • Specific Oral Tolerance Induction1

Active Sponsors

  • Imperial College London2
  • Imelda Hospital, Bonheiden2
  • Dominque Bullens2
  • Public Health England2
  • University Hospital Southampton NHS Foundation Trust2

Top Investigators

Related Conditions

  • Milk Hypersensitivity1
  • Food Hypersensitivity1
  • Food Allergy In Children1
  • Food Allergies1
  • Egg Allergy1

Activity Timeline